Assessment of acquired hypothalamic obesity and fatigue burden in patients and caregivers of patients with craniopharyngioma

Clicks: 2
ID: 324225
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #39 of 42 articles by views in Neuro-Oncology Practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Patients with childhood and adult-onset craniopharyngioma (CP), a low-grade brain tumor in the hypothalamic-pituitary region, experience persistent symptoms associated with the disease and its treatment. Tumor and treatment-related hypothalamic dysfunction increase the risk for developing acquired hypothalamic obesity (HO) and fatigue. Studies on caregiver or patient-reported symptom burden of CP, particularly those associated with acquired HO and fatigue, remain limited. Methods Individuals and caregivers responded to online surveys in an international hypothalamic-pituitary brain tumor registry on the patient experience of living with CP. Questionnaires captured patient demographic and clinical characteristics, fatigue severity, daytime sleepiness, impact on daily functioning, and treatment approaches. Fatigue and daytime sleepiness were assessed using validated instruments. Responses were analyzed and stratified according to respondent type and acquired HO status. Results 103 patients (mean age: 26.0 years; SD: 16.0) with CP or their caregivers completed surveys. Respondents reported living with a high burden of disease, even many years after diagnosis. Patients with acquired HO had a higher number of comorbidities than those without acquired HO (mean 16.8 vs. 11.8 symptoms), and 72.8% of patients experienced fatigue. Individuals with acquired HO reported significantly greater fatigue, daytime sleepiness, and impairment in activities of daily living than those without an HO diagnosis. Despite widespread use, fewer than one-third of respondents found fatigue-management strategies effective. Conclusions Fatigue is highly prevalent among patients with CP and is more severe in those with acquired HO, creating a substantial disease burden impacting daily life. Effective treatment options remain limited, highlighting a significant unmet clinical need.
Reference Key
openalex_W7196988060 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Daisy Duan, Hanneke M. van Santen, Nathalie Kayadjanian, Jieruo Liu, Usha Mallya, Jason C Simeone, Laura Cilek, Scott Coven
Journal Neuro-Oncology Practice
Year 2026
DOI
10.1093/nop/npag080
URL
https://doi.org/10.1093/nop/npag080
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.